Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 20/20 | 0.71 |
| ▸ | ECE1 | P42892 | 1/20 | 0.66 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30691823 | 1.00 | GLP1R (0.71) | GLP1RECE1MUS81 | |
| SCHEMBL30658231 | 0.92 | GLP1R (0.70) | GLP1RECE1MUS81 | |
| SCHEMBL30887554 | 0.90 | C5AR1 (0.66) | GLP1RECE1MUS81 | |
| SCHEMBL29942605 | 0.90 | GLP1R (0.84) | GLP1R | |
| SCHEMBL28662518 | 0.90 | GLP1R (0.84) | GLP1R | |
| SCHEMBL31099271 | 0.90 | GLP1R (0.84) | GLP1R | |
| SCHEMBL29431871 | 0.90 | GLP1R (0.84) | GLP1R | |
| SCHEMBL29801807 | 0.90 | GLP1R (0.84) | GLP1R | |
| SCHEMBL30607448 | 0.89 | GLP1R (0.67) | GLP1R | |
| SCHEMBL29604164 | 0.89 | C5AR1 (0.65) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230135945-A1 | Method for Measuring Modulation in the Activity of a G Protein-Coupled Receptor | CISBIO ASSAYS (FR) | 2023-05-04 | — | — | US | claimed |
| US-20220099669-A1 | METHOD FOR MEASURING THE MODULATION OF THE ACTIVATION OF A G PROTEIN-COUPLED RECEPTOR WITH GTP ANALOGUES | CISBIO BIOASSAYS (FR) | 2022-03-31 | — | — | US | claimed |
| US-12584916-B2 | Method for measuring the modulation of the activation of a G protein-coupled receptor with GTP analogues | CISBIO BIOASSAYS (FR) | 2026-03-24 | — | — | US | disclosed |
| US-20230135945-A1 | Method for Measuring Modulation in the Activity of a G Protein-Coupled Receptor | CISBIO ASSAYS (FR) | 2023-05-04 | — | — | US | disclosed |
| US-20220099669-A1 | METHOD FOR MEASURING THE MODULATION OF THE ACTIVATION OF A G PROTEIN-COUPLED RECEPTOR WITH GTP ANALOGUES | CISBIO BIOASSAYS (FR) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584916-B2 | Method for measuring the modulation of the activation of a G protein-coupled receptor with GTP analogues | GNAI1, GNAI3, GNB1 | GLP1R 156/4885ECE1 3130/4885MUS81 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.